{"id":"https://openalex.org/W2007168079","doi":"https://doi.org/10.1177/0269881111405360","title":"Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial","display_name":"Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial","publication_year":2011,"publication_date":"2011-06-21","ids":{"openalex":"https://openalex.org/W2007168079","doi":"https://doi.org/10.1177/0269881111405360","mag":"2007168079","pmid":"https://pubmed.ncbi.nlm.nih.gov/21693549"},"language":"en","primary_location":{"id":"doi:10.1177/0269881111405360","doi":"https://doi.org/10.1177/0269881111405360","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881111405360","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019918379","display_name":"Sallie Jo Hadley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sallie J Hadley","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048939577","display_name":"Francine S. Mandel","orcid":"https://orcid.org/0000-0002-9258-2452","observed_orcids":["https://orcid.org/0000-0002-9258-2452"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francine S Mandel","raw_affiliation_strings":["Pfizer, Inc., New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091485152","display_name":"Edward Ernest Schweizer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Schweizer","raw_affiliation_strings":["Paladin Consulting Group, Hoboken, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paladin Consulting Group, Hoboken, NJ, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":5.3391,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.94565509,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"26","issue":"4","first_page":"461","last_page":"470"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.8901000022888184,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.8901000022888184,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.014700000174343586,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/benzodiazepine-tapering","display_name":"benzodiazepine tapering","score":0.8870000243186951},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.8289999961853027},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.9850000143051147},{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":0.8759999871253967},{"id":"https://openalex.org/keywords/anxiety-symptoms","display_name":"anxiety symptoms","score":0.5389999747276306},{"id":"https://openalex.org/keywords/withdrawal-symptoms","display_name":"withdrawal symptoms","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.9137322902679443},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7534379363059998},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.7196292281150818},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.70766282081604},{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.6168668270111084},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6057259440422058},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5549272298812866},{"id":"https://openalex.org/C2777696351","wikidata":"https://www.wikidata.org/wiki/Q5644839","display_name":"Hamilton Anxiety Rating Scale","level":3,"score":0.539985179901123},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5345180630683899},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.4965584874153137},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43833550810813904},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.38409578800201416},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22898134589195251},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881111405360","doi":"https://doi.org/10.1177/0269881111405360","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881111405360","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:21693549","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21693549","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320315137","display_name":"Neurocrine Biosciences","ror":"https://ror.org/05d84mm26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W25113821","https://openalex.org/W199732434","https://openalex.org/W1950497346","https://openalex.org/W1967384063","https://openalex.org/W1969995105","https://openalex.org/W1977042570","https://openalex.org/W1980843180","https://openalex.org/W1981776119","https://openalex.org/W1982344701","https://openalex.org/W1985329916","https://openalex.org/W1992786849","https://openalex.org/W1996454411","https://openalex.org/W1998935547","https://openalex.org/W2016763640","https://openalex.org/W2029057559","https://openalex.org/W2033856902","https://openalex.org/W2035246885","https://openalex.org/W2047445567","https://openalex.org/W2053293311","https://openalex.org/W2059057223","https://openalex.org/W2079449062","https://openalex.org/W2084252616","https://openalex.org/W2085295826","https://openalex.org/W2085661237","https://openalex.org/W2087176798","https://openalex.org/W2087514978","https://openalex.org/W2091589270","https://openalex.org/W2091943926","https://openalex.org/W2092335293","https://openalex.org/W2094656628","https://openalex.org/W2108608442","https://openalex.org/W2114613490","https://openalex.org/W2114928716","https://openalex.org/W2123838577","https://openalex.org/W2129632383","https://openalex.org/W2133039415","https://openalex.org/W2151756295","https://openalex.org/W2160070901","https://openalex.org/W2160797858","https://openalex.org/W2164627377","https://openalex.org/W2170536966","https://openalex.org/W2272767685","https://openalex.org/W2400991648","https://openalex.org/W2418677768","https://openalex.org/W3090293687"],"related_works":["https://openalex.org/W2002032201","https://openalex.org/W2160073659","https://openalex.org/W2154996005","https://openalex.org/W2784016584","https://openalex.org/W2132270420","https://openalex.org/W2116877428","https://openalex.org/W2035246885","https://openalex.org/W1967384063","https://openalex.org/W2391063483","https://openalex.org/W2133039415"],"abstract_inverted_index":{"To":[0],"evaluate":[1],"the":[2,47,147,175,183,187,190,198,204],"efficacy":[3],"of":[4,20,49,59,78,124],"pregabalin":[5,64,129,138,176,214],"in":[6,46,107,146,174,182],"facilitating":[7],"taper":[8,74],"off":[9],"chronic":[10],"benzodiazepines,":[11],"outpatients":[12],"(N":[13],"=":[14,169],"106)":[15],"with":[16,33,62,131,137,141],"a":[17,34,71,76,84,120,194,217],"lifetime":[18],"diagnosis":[19,25],"generalized":[21],"anxiety":[22,205],"disorder":[23],"(current":[24],"could":[26],"be":[27,216],"subthreshold)":[28],"who":[29],"had":[30],"been":[31],"treated":[32],"benzodiazepine":[35,73,225],"for":[36,41,222],"8-52":[37],"weeks":[38,43,58],"were":[39,53],"stabilized":[40],"2-4":[42],"on":[44,197,203],"alprazolam":[45],"range":[48],"1-4":[50],"mg/day.":[51],"Patients":[52],"then":[54],"randomized":[55],"to":[56,99,192,213],"12":[57],"double-blind":[60,92],"treatment":[61],"either":[63],"300-600":[65],"mg/day":[66],"or":[67],"placebo":[68,132,152,184],"while":[69],"undergoing":[70],"gradual":[72],"at":[75],"rate":[77],"25%":[79],"per":[80],"week,":[81],"followed":[82],"by":[83],"6-week":[85],"benzodiazepine-free":[86,101,127],"phase":[87],"during":[88],"which":[89],"they":[90],"continued":[91],"study":[93],"treatment.":[94],"Outcome":[95],"measures":[96,209],"included":[97],"ability":[98],"remain":[100],"(primary)":[102],"as":[103,105],"well":[104],"changes":[106],"Hamilton":[108],"Anxiety":[109],"Rating":[110],"Scale":[111],"(HAM)-A":[112],"and":[113,159,178,206,219],"Physician":[114],"Withdrawal":[115],"Checklist":[116],"(PWC).":[117],"At":[118],"endpoint,":[119],"non-significant":[121],"higher":[122],"proportion":[123],"patients":[125,172,180],"remained":[126],"receiving":[128],"compared":[130],"(51.4%":[133],"vs":[134,154,166],"37.0%).":[135],"Treatment":[136],"was":[139],"associated":[140],"significantly":[142],"greater":[143],"endpoint":[144,161],"reduction":[145],"HAM-A":[148],"total":[149],"score":[150],"versus":[151],"(-2.5":[153],"+1.3;":[155],"p":[156,168],"<":[157],"0.001),":[158],"lower":[160],"mean":[162],"PWC":[163],"scores":[164],"(6.5":[165],"10.3;":[167],"0.012).":[170],"Thirty":[171],"(53%)":[173],"group":[177,185],"19":[179],"(37%)":[181],"completed":[186],"study,":[188],"reducing":[189],"power":[191],"detect":[193],"significant":[195],"difference":[196],"primary":[199],"outcome.":[200],"The":[201],"results":[202],"withdrawal":[207],"severity":[208],"suggest":[210],"that":[211],"switching":[212],"may":[215],"safe":[218],"effective":[220],"method":[221],"discontinuing":[223],"long-term":[224],"therapy.":[226]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}